<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-127643</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Casual diagnosis of Gitelman's syndrome</dc:title>
<dc:description xml:lang="en">Gitelman's syndrome is a renal tubule disease of recessive autosomal inheritance in which the fundamental alteration is found in the distal tubule, specifically at the level of the Na/Cl cotransporter, is sensitive to thiazides, and coded in chromosome 16q. It is characterised by a metabolic alkalosis with normal blood pressure, hypokalaemia, as well as hypomagnesaemia and hypocalciuria, which separate it from Bartter's syndrome. Its diagnosis can be delayed up to the adult age, as patients may remain asymptomatic for long periods of time. The treatment consists of oral supplements of potassium and magnesium, and the use of potassium-sparing diuretics and indomethacin has also been described (AU)</dc:description>
<dc:creator>Lafarga-Giribets, M. A</dc:creator>
<dc:creator>Rodrigo-Claverol, M. D</dc:creator>
<dc:creator>Garcia-Esteve, L</dc:creator>
<dc:creator>Martín-Miguel, V</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de Gitelman es una tubulopatía de herencia autosómica recesiva en el que la alteración fundamental se halla en el túbulo distal, concretamente a nivel del cotransportador Na/Cl, sensible a las tiazidas, codificado en el cromosoma 16q. Cursa con alcalosis metabólica con normotensión, hipopotasemia, así como hipomagnesemia e hipocalciuria que la diferencian del síndrome de Bartter. Su diagnóstico puede demorarse hasta la edad adulta ya que los pacientes pueden mantenerse asintomáticos durante largos períodos de tiempo. El tratamiento consiste en suplementos orales de potasio y magnesio, así como también se ha descrito la utilidad de diuréticos ahorradores de potasio e indometacina (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);40(7): e95-e98, oct. 2014.</dc:source>
<dc:identifier>ibc-127643</dc:identifier>
<dc:title xml:lang="es">Diagnóstico casual de un síndrome de Gitelman</dc:title>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7186^s22016</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d11756^s22074</dc:subject>
<dc:subject>^d52125^s22032</dc:subject>
<dc:subject>^d52125^s22016</dc:subject>
<dc:subject>^d7186^s22012</dc:subject>
<dc:subject>^d1498^s22016</dc:subject>
<dc:subject>^d473^s22012</dc:subject>
<dc:subject>^d52125^s22080</dc:subject>
<dc:subject>^d473^s22044</dc:subject>
<dc:subject>^d28146^s22073</dc:subject>
<dc:subject>^d1498^s22012</dc:subject>
<dc:subject>^d11626^s22073</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:subject>^d11756^s22066</dc:subject>
<dc:type>article</dc:type>
<dc:date>201410</dc:date>
</metadata>
</record>
</ibecs-document>
